The Ocular Correlate of Autonomic and Affective Dysregulation: Pupillometry as a Translational Biomarker in Trauma, Dissociation, and Psychedelic-Assisted Healing

I. Introduction

1.1 Contextualizing the Embodied Unconscious and ANS Dysregulation

Psychological trauma is fundamentally a disorder of systemic autonomic nervous system (ANS) regulation, often manifesting as an inability to appropriately modulate physiological arousal in response to environmental cues. While subjective reports and behavioral observations have historically been the primary means of assessing trauma response, advancements in psychophysiology necessitate the development of objective, non-invasive metrics to quantify these internal, often non-conscious states.[1] The concept of the embodied unconscious posits that deeply ingrained emotional and threat-related memories are stored and expressed through bodily regulatory mechanisms, bypassing cognitive awareness. Pupillometry offers a unique methodology to capture this phenomenon.[2, 3]

The relationship between involuntary physiological responses, emotional arousal, and cognitive effort has long been established in psychological science.[4, 5] The pupil, controlled by antagonistic muscles innervated by the sympathetic and parasympathetic divisions of the ANS, acts as an objective, readily measurable correlate of central nervous system (CNS) function.[1] Trauma-related psychopathology, particularly Post-Traumatic Stress Disorder (PTSD), is characterized by systemic autonomic dysregulation, typically involving inappropriate hyper- or hypo-arousal.[6, 7] The ability of the eye to serve as a non-invasive window into the nervous system provides an objective index of the non-conscious, embodied state that underpins the trauma response—what may be referred to as the “ocular correlate” of the embodied unconscious.

1.2 Purpose and Structure

The primary objective of this paper is to synthesize extant empirical evidence demonstrating the utility of pupillary dynamics as a robust, measurable correlate for trauma-related psychopathology and, further, as a predictive biomarker for therapeutic mechanisms. Special attention is paid to the emerging field of psychedelic-assisted therapy (PAT), where objective physiological markers are crucial for validating mechanism and predicting outcome. The subsequent sections will detail the neurophysiological basis of pupillary control, analyze the specific pupillary signatures of trauma and dissociation, examine the role of pupillometry in monitoring PAT states (MDMA, Psilocybin, Ketamine), and finally, address critical clinical translation and methodological imperatives.

II. The Neurophysiological Architecture of Pupillary Dynamics and Arousal Control

2.1 Dual Innervation: Sympathetic, Parasympathetic, and the Pupillary Light Reflex (PLR)

Pupil size is precisely regulated by the antagonistic actions of two key muscles in the iris: the sphincter muscle, innervated by the parasympathetic nervous system (PNS), and the dilator muscle, innervated by the sympathetic nervous system (SNS).[1, 8] The Pupillary Light Reflex (PLR) describes the initial constriction and subsequent redilation in response to light, providing a fundamental metric of autonomic function.[1]

The kinetics of the PLR yield distinct indicators of autonomic balance. Parameters such as maximum constriction velocity (MCV) and the amplitude of constriction are predominantly mediated by the PNS.[1] In contrast, the speed of redilation following light exposure is largely influenced by the sympathetic rebound and central arousal mechanisms. While noxious stimulation usually dilates the pupil primarily via sympathetic mediation in an unanesthetized state, the influence of central processing is significant.[8] Acute mental stress or cognitive processing has been shown to influence the PLR pattern, sometimes leading to a prolonged pupil constriction, indicative of a greater parasympathetically-mediated response following stress.[9]

2.2 The Locus Coeruleus-Norepinephrine (LC-NE) System and Psychosensory Pupil Response (PPR)

Beyond light reactivity, pupil diameter variation serves as a highly sensitive metric for inner cognitive processes, emotional processing, and attentional allocation.[2] This linkage is primarily mediated by the Locus Coeruleus-Norepinephrine (LC-NE) system. The LC, a small brainstem nucleus, is the main source of norepinephrine (NE) in the brain, functioning as the key regulator of general arousal, attention, and cognitive control.[10, 11]

Phasic pupil dilation—the psychosensory pupil response (PPR)—is recognized as a robust, non-invasive index of LC activity and subsequent NE release.[4, 11] This dilation tracks high-level cognitive processes, mental effort, and emotional salience, independent of the hedonic valence (pleasant or unpleasant) of the stimulus.[4, 12] The critical functional implication of this is that the pupillary response does not merely track arousal; it tracks a system—the LC-NE system—that is a critical mediator of cortical plasticity.[10] The release of NE is vital for rapid reorganization of neural networks in response to salient changes. Therefore, measuring sustained or profound pupillary changes during therapeutic interventions, particularly those designed to facilitate neural reorganization, provides a measurable index of the brain’s readiness to reorganize. This suggests that the magnitude and duration of pupil dilation can correlate with the temporal window of heightened cortical plasticity required for therapeutic change.

2.3 Polyvagal Theory (PVT) and Neuroception: Mapping the Embodied Unconscious

Polyvagal Theory (PVT) provides an integrative framework for understanding how the ANS regulates behavior and emotional processes in a hierarchical manner.[13, 14] The three regulatory branches—the evolutionarily newest Ventral Vagal Complex (social engagement), the Sympathetic Mobilization system (fight/flight), and the Dorsal Vagal Complex (shutdown/freeze)—govern specific involuntary bodily reactions, including heart rate and eye pupil dilation and constriction.[13]

Central to PVT is the concept of “Neuroception,” defined as the non-conscious neural process by which the organism detects cues of safety or threat in the environment.[13, 14] Because the sympathetic pathway responsible for pupillary dilation is one of the three critical branches, pupillometry offers a valuable tool for objectively quantifying Neuroception. By measuring baseline pupil size and reactivity (PLR/PPR) prior to and during therapeutic engagement, psychophysiological researchers can quantitatively assess the patient’s implicit state of safety or threat. A patient exhibiting elevated baseline pupil diameter or rapid, exaggerated PPR to minimal stimulation, even in a purportedly safe environment, demonstrates an implicit state of threat (sympathetic mobilization) that precedes conscious awareness. Thus, pupillometry provides a physiological measurement for assessing Porges’ construct of neuroception.

System	Primary Pathway/Neurotransmitter	Iris Muscle Affected	Typical Pupillary Response	Key Pupillometric Metric	Physiological Correlate
Parasympathetic	Edinger-Westphal → CN III / Acetylcholine	Sphincter Muscle (Constriction)	Constriction (PLR)	Maximum Constriction Velocity (MCV), PLR Amplitude	Resting Arousal, Inhibition, Light Regulation
Sympathetic	LC → IML → SCG / Norepinephrine	Dilator Muscle (Dilation)	Dilation (PPR)	Baseline Diameter, Peak Dilation Amplitude/Latency	Cognitive Effort, Emotional Arousal, Attentional Gain

III. Pupillometric Signatures of Trauma and Dissociative Psychopathology

3.1 Dysregulated Arousal in PTSD: Hyperarousal and Parasympathetic Deficits

Psychological trauma, particularly PTSD, is characterized by systemic autonomic dysfunction. Pupillometry studies consistently show that individuals with PTSD demonstrate enhanced physiological arousal.[6] Specifically, they exhibit an exaggerated pupil dilation in response to salient stimuli, irrespective of hedonic valence—meaning the dilation occurs in response to both graphic violence (negative) and exciting sports action (positive) images.[6, 15] This heightened response indicates a generalized state of sympathetic hyperarousal where the LC-NE system is highly reactive to any stimulus deemed salient, confirming the failure of the system to correctly determine threat vs. safety.

Furthermore, studies have identified a crucial deficit in inhibitory control in these populations. Individuals with PTSD show reduced pupil constriction to stimulus onset, suggesting a compromised capacity for parasympathetic arousal or rapid dampening of the sympathetic response.[6, 15] This autonomic pattern—increased sympathetic overdrive (hyperarousal) coupled with deficient parasympathetic restraint—is linked to a range of adverse health outcomes associated with PTSD. Pupil reactivity, therefore, shows significant promise as a diagnostic physiological marker, accounting for 12% of the variability in PTSD status and achieving high classification accuracy in initial models.[7, 16]

3.2 Dissociation: Tracking the Shift from Mobilization to Freeze

Pathological dissociation represents an alternative, often more extreme, manifestation of trauma response, involving detachment from surroundings, altered sense of self, and memory failure.[17] Under the PVT model, this detachment often aligns with the dorsal vagal “freeze” or shutdown state, a state of profound hypoarousal. While sympathetic hyperarousal is clearly linked to dilation, dissociation presents a more complex pupillary profile.

The instability inherent in complex trauma often involves the rapid oscillation between sympathetic mobilization (fight/flight/hyperarousal) and dorsal vagal shutdown (freeze/dissociation). The key informative physiological signature of this complex trauma structure may not be the peak magnitude of dilation, but rather the instability or abnormal time course of the pupillary response. Specifically, the inability of the parasympathetic system to rapidly restore homeostasis after sympathetic activation reflects a brittle autonomic system constantly toggling between extreme states. Although direct pupillometry correlation with dissociation measures such as the Clinician-Administered Dissociative State Scale (CADSS) is still a necessary area of research, the physiological signature of dissociation should theoretically involve a dampening or slowing of the PPR, reflecting a neurological detachment from sensory and emotional input.[18]

3.3 Clinical Applications: Monitoring Intervention Engagement

The ability to objectively track non-conscious physiological states makes pupillometry an invaluable tool for clinical intervention guidance. Recent research demonstrates that pupil size can track intervention engagement and subsequently predict symptom reduction in evidence-based digital treatments for trauma, such as the Imagery Competing Task Intervention (ICTI).[19, 20] This moves pupillometry from a purely diagnostic role into a prognostic and process-monitoring function.

Successful trauma processing requires the patient to operate within their “Window of Tolerance”—a state of optimal emotional engagement that avoids both overwhelming distress (hyperarousal) and emotional detachment (dissociation). Pupillometry provides objective, real-time data to help clinicians maintain a patient within this window. Rapid, excessive dilation during recall indicates that the patient is approaching sympathetic hyperarousal and may be overwhelmed, necessitating a pause or shift in focus. Conversely, stable, small pupils during emotionally salient material might suggest dissociation, indicating insufficient engagement for meaningful therapeutic work. This real-time physiological biofeedback can guide the therapist’s pacing, ensuring the patient remains maximally engaged in the neuroplasticity window signaled by NE release without triggering psychological shutdown. This capacity to identify individuals at risk for developing long-lasting emotional scars and to monitor treatment efficacy has immense public health and clinical utility, including screening first responders or military personnel.[7]

IV. Pupillary Biomarkers in Psychedelic-Assisted Therapy (PAT)

4.1 MDMA-Assisted Therapy (MDMA-AT): Tracking Empathogenic Arousal

Psychedelic compounds, particularly 3,4-methylenedioxymethamphetamine (MDMA), produce profound physiological effects that are highly relevant to pupillometric monitoring. MDMA is classified as an empathogen-entactogen, promoting the release of serotonin and dopamine and elevating hormones that facilitate greater social engagement, openness, empathy, and disclosure of emotional content.[21] Pharmacologically, MDMA, alongside other compounds like LSD, generates powerful sympathomimetic effects, resulting in marked increases in cardiovascular parameters, body temperature, and significant pupillary dilation.[22, 23]

The sustained pupil dilation observed during MDMA-AT is the ocular correlate of the acute therapeutic state. This state is characterized by maximal sympathetic activation (high NE and arousal, correlating with the plasticity window identified in Section 2.2) combined with serotonergic openness. Pupillometry offers a continuous, high-resolution metric of this acute physiological load, which is essential given that clinical protocols mandate close monitoring of sympathetic effects such as heart rate and blood pressure.[24] The high, sustained NE-driven PPR signature in MDMA-AT reflects a state optimized for emotional processing, defenseless communication, and neural connectivity.

4.2 Psilocybin and the Emotional Breakthrough Correlate

Psilocybin exerts its psychoactive effects primarily through 5-HT2A receptor agonism, leading to profound alterations in perception and cognition, particularly within the Default Mode Network (DMN).[25] Like MDMA, psilocybin induces significant, dose-dependent pupil dilation. Critically, the subjective experiences induced by psilocybin, such as “emotional breakthrough” and “mystical-type experience,” are strong predictors of long-term reduction in symptom severity (e.g., depression).[26]

The transient hyper-plastic state induced by psilocybin is associated with specific changes in neural processing that extend beyond the acute intoxication phase.[27] For instance, reorganization in cortical networks is thought to temporarily weaken pathological top-down belief structures and enhance bottom-up signaling, aligning with predictive processing theories of psychedelic action.[27] Pupillometry can serve as an objective measure of this neurobiological shift. The magnitude and kinetics of dilation during the acute session track the intensity of the neuroplasticity window. Furthermore, monitoring pupillary responses in follow-up integration sessions may confirm the stability of the long-term therapeutic effect. A return to normalized baseline pupil size and regulated PPR/PLR kinetics post-treatment would provide an objective biomarker of successful emotional integration and sustained reduction in chronic hyperarousal symptoms, thereby confirming the long-term impact of the acute psychedelic state.

4.3 Ketamine and the Measurement of Dissociative Depth

Ketamine, an NMDA receptor antagonist, reliably induces therapeutic dissociation—a temporary state of detachment and altered perception.[28] Dissociation is considered beneficial in trauma therapy because it allows individuals to confront and process traumatic memories without experiencing overwhelming emotional distress.[28] The depth of this psychological detachment is typically assessed using instruments like the Clinician-Administered Dissociative State Scale (CADSS).[18]

As pupillometry is a measure of ANS engagement and cognitive effort, it offers a pathway to quantifying the dissociative state objectively. If dissociation involves a withdrawal of attention and emotional connectivity, the pupillary dynamics should reflect this state. The pupillary signature of therapeutic ketamine is likely complex, but measuring the pupillary response to an affective or cognitive task should reveal a measurable reduction in PPR amplitude, correlating inversely with the CADSS score. This objective measurement could validate the dissociative depth achieved without relying solely on subjective self-report or intermittent clinical scoring. Whereas the MDMA pupillary signature reflects a highly connective and emotionally engaged state, the pupillary signature of ketamine reflects a neurological detachment mechanism necessary for processing trauma memories without emotional flooding.

Agent	Primary Pharmacological Mechanism	Reported Pupillary Response	Associated Acute Clinical State	Hypothesized Pupillometric Biomarker Utility
MDMA	Serotonin/Dopamine Release, NET/SERT Inhibition	Marked, Sustained Dilation (Sympathomimetic) [22, 23]	Emotional Openness, Empathy, High Engagement [21]	Index of Peak Sympathetic/LC-NE Activation and Plasticity Window
Psilocybin	5-HT2A Receptor Agonism, DMN Disruption [25]	Significant Dilation (Dose-Dependent)	Mystical/Emotional Breakthrough, Altered Perception [26]	Tracking the shift in Predictive Processing and Top-Down Control [27]
Ketamine	NMDA Receptor Antagonism	Variable; Likely reduced PLR/PPR responsiveness	Dissociation, Detachment, Altered Consciousness [18, 28]	Objective, Continuous Measure of Dissociative Depth (Surrogate for CADSS)

V. Clinical Translation and Methodological Rigor

5.1 Challenges in Standardization and Protocol Development

For pupillometry to transition effectively from laboratory tool to clinical diagnostic standard, standardization of measurement protocols is paramount.[29] Current research highlights significant methodological variability that threatens generalizability and clinical applicability. A critical challenge lies in the selection and application of baseline metrics. Research indicates that apparent pupil differences intended to index online processing may, in fact, be artifacts resulting from the chosen baseline normalization window.[30] Furthermore, the inherently slow nature of pupillary change can render it incompatible with rapidly presented visual or cognitive stimuli, leading to misinterpretation of results in fast-paced experimental paradigms.[30]

To mitigate subjectivity and ensure accuracy, the adoption of automated, Quantitative Pupillometry (QP) devices is strongly advocated.[31] Historically, manual pupillary assessment using a penlight is prone to high inter-examiner variability and significant error (up to 39%), relying on subjective descriptors like “sluggish” or “brisk”.[32] QP provides objective, continuous measurement of pupil size, reactivity, and PLR kinetics, similar to its established use in monitoring traumatic brain injury (TBI) and guiding neurosurgical triage.[32, 33, 34, 35] Standardization of measurement protocols—including ambient light, baseline duration, and time of day—and the development of robust normative data across diverse populations are necessary prerequisites for widespread clinical integration.[29]

5.2 Reliability and Validity in Clinical Populations

Reliability data indicates that pupillometry metrics, such as pupil diameter and fluctuation, generally exhibit good relative reliability (Intraclass Correlation Coefficients, ICC, ranging from 0.66 to 0.87).[36] However, absolute reliability, particularly the Minimal Detectable Change (MDC), must be closely scrutinized when tracking subtle clinical progress. For certain metrics, the MDC can represent a large percentage of baseline values.[36]

The significant impact of baseline selection and measurement variability contributes to a reliability gap that hinders broad clinical utility. For pupillometry to become a gold standard clinical measurement, similar to the Glasgow Coma Scale (GCS) in neurotrauma [32], standardized protocols must be rigorously enforced to minimize the MDC. Without this level of consistency, pupillometry’s utility remains focused on tracking large, acute changes (e.g., peak drug effects or severe trauma responses) rather than reliably detecting subtle, day-to-day fluctuations in mild symptomology. This constraint may explain mixed findings in some studies where pupillometric variables did not correlate significantly with general trait measures, such as preoperative anxiety levels, suggesting the technique may be better suited for tracking acute, state-dependent processing or specific LC-NE activity rather than global anxiety traits.[37]

5.3 Ethical and Implementation Considerations

The expanded utility of pupillometry in psychiatry introduces several critical ethical considerations.[3] While the process itself is non-invasive and painless [38], the ability of the technology to track non-conscious emotional or cognitive processing raises concerns regarding data privacy and the interpretation of involuntary physiological information.[39]

The use of pupillometry for early risk assessment in trauma, such as screening individuals prior to deployment, carries a significant societal responsibility.[7] Employing a non-conscious physiological measure for screening or triage requires stringent ethical frameworks to prevent diagnostic overreach or unjust profiling based solely on involuntary physiological responses. Furthermore, as pupillometry can reveal discrepancies between a patient’s conscious self-report and their embodied physiological state (Neuroception), informed consent must explicitly detail the potential for the technology to reveal these non-conscious vulnerabilities. Researchers and clinicians must ensure transparency and avoid making definitive diagnoses solely based on pupillary data, treating it instead as complementary objective evidence.

Conversely, pupillometry also offers profound therapeutic augmentation potential. When used in a biofeedback context (Pupil-BF), participants can acquire a transferable skill to self-regulate pupil size. This demonstrates that the brain’s arousal system can be made accessible to voluntary control, linking pupil down-regulation to deactivation in arousal centers like the LC-NE system.[40] This potential for patients to gain conscious control over formerly non-conscious autonomic responses represents a significant advancement in self-regulation training for affective disorders.

VI. Discussion: The Embodiment of Healing

6.1 Synthesis: The LC-NE System as the Gatekeeper of Trauma Processing

The comprehensive analysis confirms that pupillary dynamics serve as the most accessible non-invasive measure of the LC-NE system and overall ANS function. The observed “ocular correlate” directly reflects the functional status of the neural networks responsible for determining emotional salience, directing attention, and regulating the internal perception of safety (Neuroception). Trauma is physiologically defined by a dysregulated system exhibiting both exaggerated mobilization (sympathetic hyperarousal/dilation) and deficient restorative capacity (parasympathetic failure/reduced constriction).[6, 15]

Psychedelic-assisted healing protocols operate by inducing a transient state of high neuroplasticity, often characterized by maximal acute sympathetic activation.[23] Pupillometry measures the integrity and magnitude of this activation, providing an objective timestamp for the therapeutic “plasticity window.” Successful therapeutic outcome, conversely, is hypothesized to involve not just the acute experience but the subsequent restoration of a balanced ANS state, evidenced by a return to normalized, regulated pupillary kinetics (PLR/PPR responsiveness) during follow-up integration sessions. The pupillary trajectory provides a full account of the healing process: from acute, heightened engagement necessary for change, to sustained autonomic balance signifying integration and symptom resolution.

6.2 Implications for PAT Protocol Optimization

The incorporation of objective pupillometric measures holds significant implications for optimizing PAT protocols. First, pupillometry can facilitate real-time dosing and intervention timing. By continuously monitoring dilation, therapists can accurately time critical therapeutic interventions—such as introducing difficult trauma material or administering the supplemental half-dose of MDMA—to coincide with the optimal autonomic state.[24] This ensures the patient is maximally engaged and susceptible to neural reorganization without crossing the threshold into overwhelming distress or dissociative shutdown.

Second, pupillometry can contribute to prognostic assessment. The magnitude of peak pupil dilation during the acute session, serving as an index of maximal NE-release and plasticity, combined with the rate of autonomic normalization in subsequent integration sessions, should be formally investigated as a composite physiological predictor for long-term symptom reduction, such as changes in the Clinician Administered PTSD Scale for DSM-V (CAPS-5) scores.[24] The ultimate goal is to identify a clear physiological threshold during the acute experience that reliably predicts long-term functional recovery.

6.3 Limitations and Future Directions

Despite the compelling theoretical and preliminary empirical support, several research gaps must be addressed to solidify pupillometry’s role as a clinical biomarker. A critical lack of published data exists correlating pupillometry directly with specific psychological state markers during the psychedelic experience. Future research must urgently address the correlation between pupillometric parameters and measures of psychological state, such as the CADSS (for ketamine dissociation) and formalized scales for assessing emotional breakthrough.[18, 26]

Furthermore, research must meticulously differentiate the pupillary effects purely attributable to the pharmacological action (e.g., sympathomimetic side effects) from those attributable to the specific cognitive and emotional processing of trauma material elicited by the therapeutic setting. Finally, prospective, longitudinal studies are essential to definitively establish whether abnormal pupillary responses precede or follow the onset of PTSD and to confirm the sustained normalization of ANS function following successful PAT.[7]

VII. Conclusion

The evidence overwhelmingly supports the use of pupillometry as a sophisticated, non-invasive technology for objectively quantifying the embodied unconscious and autonomic dysregulation central to trauma-related psychopathology. The pupil provides a translational bridge between complex, subjective human experience and the measurable, underlying mechanics of the LC-NE system and the ANS. By utilizing quantitative pupillometry and standardized protocols, clinicians can leverage the ocular correlate to enhance diagnostic precision, guide therapeutic interventions in real-time, and objectively validate the mechanism and long-term efficacy of emerging treatments like psychedelic-assisted therapy. The continued expansion of pupillometry promises to usher in an era of physiologically informed, personalized trauma care.

——————————————————————————–

1. Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics – MDPI, https://www.mdpi.com/2075-4418/8/1/19

2. Pupillometry: A Simple and Automatic Way to Explore Implicit Cognitive Processing – PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11986704/

3. Pupillary Motility: Bringing Neuroscience to the Psychiatry Clinic of the Future – PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3951920/

4. Pupillometry: Psychology, Physiology, and Function – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC6634360/

5. Unconscious pupillometry: An effect of “attentional contagion” in the absence of visual awareness – PubMed, https://pubmed.ncbi.nlm.nih.gov/34435801/

6. Enhanced emotional response to both negative and positive images in post-traumatic stress disorder: Evidence from pupillometry – PubMed, https://pubmed.ncbi.nlm.nih.gov/32565340/

7. Pupil response to threat: A physiological marker for PTSD? – Cascade, Armstrong, & Chung, https://istss.org/pupil-response-to-threat-a-physiological-marker-for-ptsd-cascade-armstrong-chung/

8. Sympathetic nervous system does not mediate reflex pupillary dilation during desflurane anesthesia – PubMed, https://pubmed.ncbi.nlm.nih.gov/8873544/

9. Acute Mental Stress is Associated With Altered Pupillary Light Reflex – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC12462696/

10. From pupil to the brain: New insights for studying cortical plasticity through pupillometry – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC10102476/

11. The Locus Coeruleus: Where Cognitive and Emotional Processing Meet the Eye | Request PDF – ResearchGate, https://www.researchgate.net/publication/380900017_The_Locus_Coeruleus_Where_Cognitive_and_Emotional_Processing_Meet_the_Eye

12. The pupil as a measure of emotional arousal and autonomic activation – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC3612940/

13. Polyvagal theory | Research Starters – EBSCO, https://www.ebsco.com/research-starters/health-and-medicine/polyvagal-theory

14. Polyvagal theory: a journey from physiological observation to neural innervation and clinical insight – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC12479538/

15. If Eyes Are a Window to the Soul, Our Pupils May Reveal PTSD | Psychology Today, https://www.psychologytoday.com/us/blog/the-athletes-way/202007/if-eyes-are-window-the-soul-our-pupils-may-reveal-ptsd

16. Pupil Response to Threat in Trauma-Exposed Individuals With or Without PTSD – PubMed, https://pubmed.ncbi.nlm.nih.gov/26215078/

17. Biomarkers of dissociation – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC10375900/

18. Ketamine and Dissociation: What is it? | Principium in NYC-Greenwich-LA, https://www.principiumpsychiatry.com/blog/ketamine-and-dissociation-what-is-it/

19. [2507.01081] AI-guided digital intervention with physiological monitoring reduces intrusive memories after experimental trauma – arXiv, https://arxiv.org/abs/2507.01081

20. AI-guided digital intervention with physiological monitoring … – arXiv, https://arxiv.org/pdf/2507.01081

21. Psychedelic-Assisted Therapy for PTSD – National Center for PTSD, https://www.ptsd.va.gov/professional/treat/txessentials/psychedelics_assisted_therapy.asp

22. Physiological and Subjective Responses to Controlled Oral MDMA Administration – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC2587205/

23. MDMA and MDMA-Assisted Therapy | American Journal of Psychiatry, https://psychiatryonline.org/doi/10.1176/appi.ajp.20230681

24. NCT03537014 | A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1), https://www.clinicaltrials.gov/study/NCT03537014

25. Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC9247433/

26. Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review – PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC12099018/

27. A lasting impact of serotonergic psychedelics on visual processing and behavior – bioRxiv, https://www.biorxiv.org/content/10.1101/2024.07.03.601959v1.full-text

28. Understanding Ketamine and Disassociation – Avesta, https://avestaketaminewellness.com/understanding-ketamine-therapy-and-disassociation/

29. Pupillometry as an Objective Measure of Auditory Perception and Listening Effort Across the Lifespan: A Review – MDPI, https://www.mdpi.com/2504-463X/6/2/24

30. Opposing Timing Constraints Severely Limit the Use of Pupillometry to Investigate Visual Statistical Learning – Frontiers, https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.01792/full

31. Measure Pupil Reactivity with NPi-200 Pupillometer- NeurOptics, https://neuroptics.com/npi-200-pupillometer/

32. Pupillometry in Critical Care | Measure Pupil Size – NeurOptics, https://neuroptics.com/pupillometry-clinical-overview/

33. Quantitative pupillometry as a sensitive biomarker for detecting subtle neurological impairment in mild traumatic brain injury – a pilot study – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC12488747/

34. The Expanding Role of Quantitative Pupillometry in the Evaluation and Management of Traumatic Brain Injury – Frontiers, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.685313/full

35. The Role of Automated Infrared Pupillometry in Traumatic Brain Injury: A Narrative Review, https://www.mdpi.com/2077-0383/13/2/614

36. Reliability and reactivity of heart rate variability and pupillometry in response to controlled autonomic perturbations in university students – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC12364972/

37. Investigating pupillometry to detect preoperative anxiety: a pilot study – Frontiers, https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2023.1296387/full

38. Pupillometry as a measure of cognitive load in mental rotation tasks with abstract and embodied figures – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC9177492/

39. Restoring sight in choice blindness: pupillometry and behavioral evidence of covert detection – Frontiers, https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1598254/full

40. Self-regulating arousal via pupil-based biofeedback – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC10810759/